List of Tables
Table 1. Global PD-1 and PDL-1 Inhibitors Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global PD-1 and PDL-1 Inhibitors Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global PD-1 and PDL-1 Inhibitors Market Competitive Situation by Manufacturers in 2024
Table 4. Global PD-1 and PDL-1 Inhibitors Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global PD-1 and PDL-1 Inhibitors Sales Market Share by Manufacturers (2020-2025)
Table 6. Global PD-1 and PDL-1 Inhibitors Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global PD-1 and PDL-1 Inhibitors Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market PD-1 and PDL-1 Inhibitors Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of PD-1 and PDL-1 Inhibitors, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of PD-1 and PDL-1 Inhibitors, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of PD-1 and PDL-1 Inhibitors, Product Type & Application
Table 12. Global Key Manufacturers of PD-1 and PDL-1 Inhibitors, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global PD-1 and PDL-1 Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PD-1 and PDL-1 Inhibitors as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global PD-1 and PDL-1 Inhibitors Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global PD-1 and PDL-1 Inhibitors Sales by Region (2020-2025) & (K Units)
Table 18. Global PD-1 and PDL-1 Inhibitors Sales Market Share by Region (2020-2025)
Table 19. Global PD-1 and PDL-1 Inhibitors Sales by Region (2026-2031) & (K Units)
Table 20. Global PD-1 and PDL-1 Inhibitors Sales Market Share by Region (2026-2031)
Table 21. Global PD-1 and PDL-1 Inhibitors Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global PD-1 and PDL-1 Inhibitors Revenue Market Share by Region (2020-2025)
Table 23. Global PD-1 and PDL-1 Inhibitors Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global PD-1 and PDL-1 Inhibitors Revenue Market Share by Region (2026-2031)
Table 25. North America PD-1 and PDL-1 Inhibitors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America PD-1 and PDL-1 Inhibitors Sales by Country (2020-2025) & (K Units)
Table 27. North America PD-1 and PDL-1 Inhibitors Sales by Country (2026-2031) & (K Units)
Table 28. North America PD-1 and PDL-1 Inhibitors Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America PD-1 and PDL-1 Inhibitors Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe PD-1 and PDL-1 Inhibitors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe PD-1 and PDL-1 Inhibitors Sales by Country (2020-2025) & (K Units)
Table 32. Europe PD-1 and PDL-1 Inhibitors Sales by Country (2026-2031) & (K Units)
Table 33. Europe PD-1 and PDL-1 Inhibitors Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe PD-1 and PDL-1 Inhibitors Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific PD-1 and PDL-1 Inhibitors Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific PD-1 and PDL-1 Inhibitors Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific PD-1 and PDL-1 Inhibitors Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific PD-1 and PDL-1 Inhibitors Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific PD-1 and PDL-1 Inhibitors Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America PD-1 and PDL-1 Inhibitors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America PD-1 and PDL-1 Inhibitors Sales by Country (2020-2025) & (K Units)
Table 42. Latin America PD-1 and PDL-1 Inhibitors Sales by Country (2026-2031) & (K Units)
Table 43. Latin America PD-1 and PDL-1 Inhibitors Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America PD-1 and PDL-1 Inhibitors Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa PD-1 and PDL-1 Inhibitors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa PD-1 and PDL-1 Inhibitors Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa PD-1 and PDL-1 Inhibitors Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa PD-1 and PDL-1 Inhibitors Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa PD-1 and PDL-1 Inhibitors Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global PD-1 and PDL-1 Inhibitors Sales (K Units) by Type (2020-2025)
Table 51. Global PD-1 and PDL-1 Inhibitors Sales (K Units) by Type (2026-2031)
Table 52. Global PD-1 and PDL-1 Inhibitors Sales Market Share by Type (2020-2025)
Table 53. Global PD-1 and PDL-1 Inhibitors Sales Market Share by Type (2026-2031)
Table 54. Global PD-1 and PDL-1 Inhibitors Revenue (US$ Million) by Type (2020-2025)
Table 55. Global PD-1 and PDL-1 Inhibitors Revenue (US$ Million) by Type (2026-2031)
Table 56. Global PD-1 and PDL-1 Inhibitors Revenue Market Share by Type (2020-2025)
Table 57. Global PD-1 and PDL-1 Inhibitors Revenue Market Share by Type (2026-2031)
Table 58. Global PD-1 and PDL-1 Inhibitors Price (US$/Unit) by Type (2020-2025)
Table 59. Global PD-1 and PDL-1 Inhibitors Price (US$/Unit) by Type (2026-2031)
Table 60. Global PD-1 and PDL-1 Inhibitors Sales (K Units) by Application (2020-2025)
Table 61. Global PD-1 and PDL-1 Inhibitors Sales (K Units) by Application (2026-2031)
Table 62. Global PD-1 and PDL-1 Inhibitors Sales Market Share by Application (2020-2025)
Table 63. Global PD-1 and PDL-1 Inhibitors Sales Market Share by Application (2026-2031)
Table 64. Global PD-1 and PDL-1 Inhibitors Revenue (US$ Million) by Application (2020-2025)
Table 65. Global PD-1 and PDL-1 Inhibitors Revenue (US$ Million) by Application (2026-2031)
Table 66. Global PD-1 and PDL-1 Inhibitors Revenue Market Share by Application (2020-2025)
Table 67. Global PD-1 and PDL-1 Inhibitors Revenue Market Share by Application (2026-2031)
Table 68. Global PD-1 and PDL-1 Inhibitors Price (US$/Unit) by Application (2020-2025)
Table 69. Global PD-1 and PDL-1 Inhibitors Price (US$/Unit) by Application (2026-2031)
Table 70. GlaxoSmithKline plc Company Information
Table 71. GlaxoSmithKline plc Description and Business Overview
Table 72. GlaxoSmithKline plc PD-1 and PDL-1 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. GlaxoSmithKline plc PD-1 and PDL-1 Inhibitors Product
Table 74. GlaxoSmithKline plc Recent Developments/Updates
Table 75. Bristol-Myers Squibb Company Company Information
Table 76. Bristol-Myers Squibb Company Description and Business Overview
Table 77. Bristol-Myers Squibb Company PD-1 and PDL-1 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Bristol-Myers Squibb Company PD-1 and PDL-1 Inhibitors Product
Table 79. Bristol-Myers Squibb Company Recent Developments/Updates
Table 80. Arcus Biosciences, Inc. Company Information
Table 81. Arcus Biosciences, Inc. Description and Business Overview
Table 82. Arcus Biosciences, Inc. PD-1 and PDL-1 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Arcus Biosciences, Inc. PD-1 and PDL-1 Inhibitors Product
Table 84. Arcus Biosciences, Inc. Recent Developments/Updates
Table 85. Agenus Inc Company Information
Table 86. Agenus Inc Description and Business Overview
Table 87. Agenus Inc PD-1 and PDL-1 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Agenus Inc PD-1 and PDL-1 Inhibitors Product
Table 89. Agenus Inc Recent Developments/Updates
Table 90. F. Hoffmann-La Roche Ltd Company Information
Table 91. F. Hoffmann-La Roche Ltd Description and Business Overview
Table 92. F. Hoffmann-La Roche Ltd PD-1 and PDL-1 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. F. Hoffmann-La Roche Ltd PD-1 and PDL-1 Inhibitors Product
Table 94. F. Hoffmann-La Roche Ltd Recent Developments/Updates
Table 95. Astra Zeneca PLC Company Information
Table 96. Astra Zeneca PLC Description and Business Overview
Table 97. Astra Zeneca PLC PD-1 and PDL-1 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Astra Zeneca PLC PD-1 and PDL-1 Inhibitors Product
Table 99. Astra Zeneca PLC Recent Developments/Updates
Table 100. Beigene Ltd Company Information
Table 101. Beigene Ltd Description and Business Overview
Table 102. Beigene Ltd PD-1 and PDL-1 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Beigene Ltd PD-1 and PDL-1 Inhibitors Product
Table 104. Beigene Ltd Recent Developments/Updates
Table 105. Incyte Corporation Company Information
Table 106. Incyte Corporation Description and Business Overview
Table 107. Incyte Corporation PD-1 and PDL-1 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Incyte Corporation PD-1 and PDL-1 Inhibitors Product
Table 109. Incyte Corporation Recent Developments/Updates
Table 110. Biocad Company Information
Table 111. Biocad Description and Business Overview
Table 112. Biocad PD-1 and PDL-1 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Biocad PD-1 and PDL-1 Inhibitors Product
Table 114. Biocad Recent Developments/Updates
Table 115. CStone Pharmaceuticals Company Information
Table 116. CStone Pharmaceuticals Description and Business Overview
Table 117. CStone Pharmaceuticals PD-1 and PDL-1 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. CStone Pharmaceuticals PD-1 and PDL-1 Inhibitors Product
Table 119. CStone Pharmaceuticals Recent Developments/Updates
Table 120. Ono Pharmaceutical Company Information
Table 121. Ono Pharmaceutical Description and Business Overview
Table 122. Ono Pharmaceutical PD-1 and PDL-1 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Ono Pharmaceutical PD-1 and PDL-1 Inhibitors Product
Table 124. Ono Pharmaceutical Recent Developments/Updates
Table 125. Merck Company Information
Table 126. Merck Description and Business Overview
Table 127. Merck PD-1 and PDL-1 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Merck PD-1 and PDL-1 Inhibitors Product
Table 129. Merck Recent Developments/Updates
Table 130. Shanghai Junshi Bioscience Co. Ltd Company Information
Table 131. Shanghai Junshi Bioscience Co. Ltd Description and Business Overview
Table 132. Shanghai Junshi Bioscience Co. Ltd PD-1 and PDL-1 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Shanghai Junshi Bioscience Co. Ltd PD-1 and PDL-1 Inhibitors Product
Table 134. Shanghai Junshi Bioscience Co. Ltd Recent Developments/Updates
Table 135. Shanghai Henlius Biotech, Inc. Company Information
Table 136. Shanghai Henlius Biotech, Inc. Description and Business Overview
Table 137. Shanghai Henlius Biotech, Inc. PD-1 and PDL-1 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Shanghai Henlius Biotech, Inc. PD-1 and PDL-1 Inhibitors Product
Table 139. Shanghai Henlius Biotech, Inc. Recent Developments/Updates
Table 140. Jiangsu HengRui Medicine Co., Ltd. Company Information
Table 141. Jiangsu HengRui Medicine Co., Ltd. Description and Business Overview
Table 142. Jiangsu HengRui Medicine Co., Ltd. PD-1 and PDL-1 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Jiangsu HengRui Medicine Co., Ltd. PD-1 and PDL-1 Inhibitors Product
Table 144. Jiangsu HengRui Medicine Co., Ltd. Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. PD-1 and PDL-1 Inhibitors Distributors List
Table 148. PD-1 and PDL-1 Inhibitors Customers List
Table 149. PD-1 and PDL-1 Inhibitors Market Trends
Table 150. PD-1 and PDL-1 Inhibitors Market Drivers
Table 151. PD-1 and PDL-1 Inhibitors Market Challenges
Table 152. PD-1 and PDL-1 Inhibitors Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of PD-1 and PDL-1 Inhibitors
Figure 2. Global PD-1 and PDL-1 Inhibitors Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global PD-1 and PDL-1 Inhibitors Market Share by Type: 2024 & 2031
Figure 4. Pembrolizumab Product Picture
Figure 5. Nivolumab Product Picture
Figure 6. Atezolizumab Product Picture
Figure 7. Durvalumab Product Picture
Figure 8. Avelumab Product Picture
Figure 9. Global PD-1 and PDL-1 Inhibitors Market Value by Application (2020-2031) & (US$ Million)
Figure 10. Global PD-1 and PDL-1 Inhibitors Market Share by Application: 2024 & 2031
Figure 11. Stomach Cancer
Figure 12. Liver Cancer
Figure 13. Kidney Ccancer
Figure 14. Bladder Cancer
Figure 15. Cervical Cancer
Figure 16. Other
Figure 17. Global PD-1 and PDL-1 Inhibitors Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global PD-1 and PDL-1 Inhibitors Market Size (2020-2031) & (US$ Million)
Figure 19. Global PD-1 and PDL-1 Inhibitors Sales (2020-2031) & (K Units)
Figure 20. Global PD-1 and PDL-1 Inhibitors Average Price (US$/Unit) & (2020-2031)
Figure 21. PD-1 and PDL-1 Inhibitors Report Years Considered
Figure 22. PD-1 and PDL-1 Inhibitors Sales Share by Manufacturers in 2024
Figure 23. Global PD-1 and PDL-1 Inhibitors Revenue Share by Manufacturers in 2024
Figure 24. Global 5 and 10 Largest PD-1 and PDL-1 Inhibitors Players: Market Share by Revenue in PD-1 and PDL-1 Inhibitors in 2024
Figure 25. PD-1 and PDL-1 Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 26. Global PD-1 and PDL-1 Inhibitors Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 27. North America PD-1 and PDL-1 Inhibitors Sales Market Share by Country (2020-2031)
Figure 28. North America PD-1 and PDL-1 Inhibitors Revenue Market Share by Country (2020-2031)
Figure 29. United States PD-1 and PDL-1 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Canada PD-1 and PDL-1 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Europe PD-1 and PDL-1 Inhibitors Sales Market Share by Country (2020-2031)
Figure 32. Europe PD-1 and PDL-1 Inhibitors Revenue Market Share by Country (2020-2031)
Figure 33. Germany PD-1 and PDL-1 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. France PD-1 and PDL-1 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. U.K. PD-1 and PDL-1 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Italy PD-1 and PDL-1 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Russia PD-1 and PDL-1 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Asia Pacific PD-1 and PDL-1 Inhibitors Sales Market Share by Region (2020-2031)
Figure 39. Asia Pacific PD-1 and PDL-1 Inhibitors Revenue Market Share by Region (2020-2031)
Figure 40. China PD-1 and PDL-1 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Japan PD-1 and PDL-1 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. South Korea PD-1 and PDL-1 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. India PD-1 and PDL-1 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Australia PD-1 and PDL-1 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. China Taiwan PD-1 and PDL-1 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Indonesia PD-1 and PDL-1 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Thailand PD-1 and PDL-1 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Malaysia PD-1 and PDL-1 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Latin America PD-1 and PDL-1 Inhibitors Sales Market Share by Country (2020-2031)
Figure 50. Latin America PD-1 and PDL-1 Inhibitors Revenue Market Share by Country (2020-2031)
Figure 51. Mexico PD-1 and PDL-1 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Brazil PD-1 and PDL-1 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Argentina PD-1 and PDL-1 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Middle East and Africa PD-1 and PDL-1 Inhibitors Sales Market Share by Country (2020-2031)
Figure 55. Middle East and Africa PD-1 and PDL-1 Inhibitors Revenue Market Share by Country (2020-2031)
Figure 56. Turkey PD-1 and PDL-1 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. Saudi Arabia PD-1 and PDL-1 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. UAE PD-1 and PDL-1 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 59. Global Sales Market Share of PD-1 and PDL-1 Inhibitors by Type (2020-2031)
Figure 60. Global Revenue Market Share of PD-1 and PDL-1 Inhibitors by Type (2020-2031)
Figure 61. Global PD-1 and PDL-1 Inhibitors Price (US$/Unit) by Type (2020-2031)
Figure 62. Global Sales Market Share of PD-1 and PDL-1 Inhibitors by Application (2020-2031)
Figure 63. Global Revenue Market Share of PD-1 and PDL-1 Inhibitors by Application (2020-2031)
Figure 64. Global PD-1 and PDL-1 Inhibitors Price (US$/Unit) by Application (2020-2031)
Figure 65. PD-1 and PDL-1 Inhibitors Value Chain
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
